Bildkälla: Stockfoto

Cyxone: Additional Information from the Rabeximod Covid-19 Trial - Redeye

We give a short comment on the additional information from the phase II trial with Rabeximod in Covid-19 patients.

We give a short comment on the additional information from the phase II trial with Rabeximod in Covid-19 patients.
Börsvärldens nyhetsbrev
ANNONSER